X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1224) 1224
Book Review (202) 202
Publication (92) 92
Newsletter (63) 63
Magazine Article (19) 19
Newspaper Article (15) 15
Book Chapter (9) 9
Conference Proceeding (6) 6
Trade Publication Article (5) 5
Dissertation (4) 4
Paper (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
dutasteride (1207) 1207
index medicus (766) 766
humans (742) 742
male (734) 734
finasteride (518) 518
urology & nephrology (394) 394
middle aged (335) 335
men (325) 325
aged (310) 310
prostate cancer (309) 309
benign prostatic hyperplasia (303) 303
prostatic hyperplasia - drug therapy (293) 293
azasteroids - therapeutic use (286) 286
prostate (264) 264
5-alpha reductase inhibitors - therapeutic use (222) 222
cancer (194) 194
treatment outcome (189) 189
finasteride - therapeutic use (159) 159
hyperplasia (153) 153
urology (147) 147
research (145) 145
5-alpha reductase inhibitors (142) 142
testosterone (137) 137
risk (136) 136
dihydrotestosterone (130) 130
urinary-tract symptoms (128) 128
care and treatment (121) 121
combination therapy (121) 121
hypertrophy (121) 121
risk factors (121) 121
efficacy (119) 119
prostatic neoplasms - prevention & control (118) 118
prostatic neoplasms - pathology (117) 117
prostatic neoplasms - drug therapy (114) 114
tamsulosin (113) 113
aged, 80 and over (108) 108
enzyme inhibitors - therapeutic use (108) 108
drug therapy, combination (103) 103
oncology (103) 103
animals (102) 102
analysis (101) 101
abridged index medicus (100) 100
double-blind method (100) 100
prevention (99) 99
adult (98) 98
pharmacology & pharmacy (98) 98
azasteroids - administration & dosage (96) 96
drug therapy (96) 96
prostate-specific antigen - blood (92) 92
health aspects (89) 89
biopsy (88) 88
azasteroids - pharmacology (87) 87
prostate - pathology (85) 85
prostatic hyperplasia - complications (82) 82
dutasteride - therapeutic use (81) 81
5-alpha reductase inhibitors - administration & dosage (80) 80
safety (80) 80
therapy (79) 79
androgens (77) 77
diagnosis (77) 77
disease progression (72) 72
dosage and administration (71) 71
progression (70) 70
lower urinary tract symptoms (68) 68
prostatic hyperplasia - pathology (68) 68
5-alpha reductase inhibitors - adverse effects (67) 67
prostate-specific antigen (67) 67
prospective studies (66) 66
azasteroids - adverse effects (65) 65
chemoprevention (65) 65
medicine, general & internal (64) 64
5-alpha-reductase inhibitors (62) 62
endocrinology & metabolism (62) 62
medical research (62) 62
androgenetic alopecia (61) 61
dual 5-alpha-reductase inhibitor (61) 61
prostate - drug effects (61) 61
5-alpha reductase inhibitors - pharmacology (60) 60
prostatic hyperplasia (60) 60
bph (58) 58
adrenergic alpha-antagonists - therapeutic use (57) 57
trial (56) 56
retrospective studies (55) 55
dermatology (54) 54
expression (54) 54
female (54) 54
follow-up studies (54) 54
alopecia (52) 52
finasteride - adverse effects (52) 52
medicine, experimental (52) 52
5-alpha-reductase inhibitor dutasteride (51) 51
quality of life (51) 51
time factors (51) 51
dose-response relationship, drug (50) 50
randomized controlled trials as topic (50) 50
article (49) 49
antigen (48) 48
radical prostatectomy (47) 47
alopecia - drug therapy (45) 45
finasteride - pharmacology (45) 45
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1222) 1222
French (27) 27
German (27) 27
Spanish (20) 20
Japanese (12) 12
Italian (9) 9
Korean (9) 9
Russian (5) 5
Chinese (2) 2
Hungarian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal of Urology, The, ISSN 0022-5347, 2017, Volume 198, Issue 1, pp. 211 - 212
Journal Article
Journal Article
Acta Urologica Japonica, ISSN 0018-1994, 04/2018, Volume 64, Issue 4, pp. 187 - 192
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2010, Volume 362, Issue 13, pp. 1192 - 1202
Dutasteride, an inhibitor of 5α-reductase in the prostate, was tested in a large, randomized trial to determine its ability to prevent prostate cancer. Over... 
MODELING APPROACH | MEDICINE, GENERAL & INTERNAL | DESIGN | THERAPY | 5-ALPHA-REDUCTASE INHIBITOR DUTASTERIDE | SENSITIVITY | FINASTERIDE | GRADE | HYPERPLASIA | PROGRESSION | PREVENTION TRIAL | Enzyme Inhibitors - adverse effects | Prostatic Neoplasms - pathology | Prostatic Hyperplasia - pathology | Double-Blind Method | Erectile Dysfunction - chemically induced | Humans | Middle Aged | 5-alpha Reductase Inhibitors | Male | Risk | Treatment Outcome | Azasteroids - therapeutic use | Enzyme Inhibitors - therapeutic use | Prostate-Specific Antigen - blood | Azasteroids - adverse effects | Prostate - pathology | Prostatic Neoplasms - genetics | Biopsy | Protein Isoforms | Dutasteride | Aged | Prostatic Neoplasms - prevention & control | Prostatic Hyperplasia - drug therapy | Heart Failure - chemically induced | Usage | Diagnosis | Health aspects | Prostate cancer | Risk factors | Patient safety | Age | Men | Tumors | Index Medicus | Abridged Index Medicus | Prostate-Specific Antigen | Erectile Dysfunction | Enzyme Inhibitors | Testosterone 5-alpha-Reductase | Prostatic Hyperplasia | Life Sciences | Prostatic Neoplasms | Azasteroids | Heart Failure | Prostate | Cancer | pathology | genetics | Urologi och njurmedicin | chemically induced | drug therapy | prevention & control | blood | adverse effects | Cancer and Oncology | Urology and Nephrology | therapeutic use | Cancer och onkologi
Journal Article
Journal Article
Der Urologe A, ISSN 0340-2592, 03/2019, Volume 58, Issue 3, p. 248
Basierend auf neuen Daten diskutieren wir das Risiko zentralnervoser Nebenwirkungen, v.a[macron]a. eingeschrankte Kognition/Demenz und depressive Storungen,... 
Dutasteride | Cognition | Prostate | Hypertrophy | Dementia
Journal Article
Chinese Pharmaceutical Journal, ISSN 1001-2494, 09/2016, Volume 51, Issue 18, pp. 1592 - 1595
Journal Article
Journal Article
Drug Design, Development and Therapy, ISSN 1177-8881, 06/2015, Volume 9, pp. 3231 - 3238
In this study, a gelatin microparticle-containing self-microemulsifying formulation (SMF) was developed using a spray-drying method to enhance the oral... 
Dutasteride | Bioavailability | Dissolution | Solubility | dutasteride | CHEMISTRY, MEDICINAL | bioavailability | VIVO EVALUATION | dissolution | DRUG-DELIVERY SYSTEM | WATER-SOLUBLE DRUGS | SOLID DISPERSION | solubility | PHARMACOLOGY & PHARMACY | ABSORPTION | SIROLIMUS | 5-alpha Reductase Inhibitors - chemistry | Emulsions | Administration, Oral | Biological Availability | Male | Polyethylene Glycols - chemistry | Rats, Sprague-Dawley | Chemistry, Pharmaceutical | Drug Carriers | Particle Size | 5-alpha Reductase Inhibitors - pharmacokinetics | Dutasteride - blood | 5-alpha Reductase Inhibitors - blood | Animals | Excipients - chemistry | 5-alpha Reductase Inhibitors - administration & dosage | Dutasteride - chemistry | Hydrophobic and Hydrophilic Interactions | Dutasteride - pharmacokinetics | Dutasteride - administration & dosage | Polyvinyls - chemistry | Gelatin - chemistry | Drugs | Drug delivery systems | Pharmacology, Experimental | Innovations | Drug metabolism | Dosage and administration | Research | Testing | Vehicles | Chemical industry | Additives | Polyethylene | Sodium lauryl sulfate | Cellulose | Dispersion | Microparticles | Sodium dodecyl sulfate | Studies | Absorption | Sodium | Gelatin | Polyethylene glycol | Pharmacy | Recrystallization | Droplets | Laboratory animals | Drying | Pharmaceuticals | Index Medicus
Journal Article